Aqueous drink composition comprising ibuprofen
    3.
    发明授权
    Aqueous drink composition comprising ibuprofen 失效
    含有布洛芬的饮料组合物

    公开(公告)号:US06287592B1

    公开(公告)日:2001-09-11

    申请号:US09319242

    申请日:1999-06-07

    申请人: Jeffrey Dickinson

    发明人: Jeffrey Dickinson

    IPC分类号: A61K9127

    摘要: An ibuprofen composition yielding an aqueous preparation having a pH of less than 7 on the addition of water to said composition which comprises one or more medicaments including an ibuprofen medicament which forms an ibuprofen active ingredient having a melting point less than 100° C., when combined with water to give an aqueous preparation having a pH of less than 7 and a phospholipid material intimately mixed with the ibuprofen medicament. The phospholipid material is capable of forming an aqueous preparation comprising an emulsion or dispersion comprising an aqueous phase substantially free of said ibuprofen active ingredient and a discrete phase consisting essentially of said phospholipid material and insoluble pharmacologically active ingredient including said ibuprofen active ingredient on the addition of water to said composition. The invention also provides aqueous drink preparations (especially heated emulsions) produced thereform and a process to prepare said aqueous drink preparations.

    摘要翻译: 布洛芬组合物在向所述组合物中加入水时产生pH小于7的水性制剂,其包含一种或多种药物,其包含形成熔点小于100℃的布洛芬活性成分的布洛芬药物,当时 与水结合,得到pH小于7的水性制剂和与布洛芬药物紧密混合的磷脂材料。 磷脂材料能够形成包含乳液或分散体的水性制剂,所述乳液或分散体包含基本上不含所述布洛芬活性成分的水相和基本上由所述磷脂材料组成的离散相和包含所述布洛芬活性成分的不溶性药理学活性成分, 水至所述组合物。 本发明还提供了生产的含水饮料制剂(特别是加热的乳液)和制备所述含水饮料制剂的方法。

    Liquid pharmaceutical compositions comprising thyroid hormones
    6.
    发明授权
    Liquid pharmaceutical compositions comprising thyroid hormones 失效
    包含甲状腺激素的液体药物组合物

    公开(公告)号:US06458842B1

    公开(公告)日:2002-10-01

    申请号:US08682779

    申请日:1996-07-31

    IPC分类号: A61K31195

    摘要: There is disclosed a liquid pharmaceutical composition comprising a therapeutic agent which comprises: one or more thyroid hormone or hormones; from about 40% to about 96% ethanol by volume; a pH adjusting agent so that the measured pH of the composition is from about 9 to about 12; and from about 4% to about 50% water by volume; which has utility in the treatment of disorders associated with an impairment of the thyroid hormone function in animals including human beings. The liquid composition may be delivered by a metered dosage delivery system such as an aerosol or pump-action spray.

    摘要翻译: 公开了包含治疗剂的液体药物组合物,其包含:一种或多种甲状腺激素或激素; 约40%至约96%乙醇; pH调节剂,使得组合物的测量pH为约9至约12; 和约4%至约50%的水; 其可用于治疗与包括人在内的动物的甲状腺激素功能受损相关的疾病。 液体组合物可以通过计量剂量递送系统例如气溶胶或泵作用喷雾来递送。

    Method and apparatus for testing multi-core microprocessors
    8.
    发明授权
    Method and apparatus for testing multi-core microprocessors 失效
    用于测试多核微处理器的方法和装置

    公开(公告)号:US07610537B2

    公开(公告)日:2009-10-27

    申请号:US11278615

    申请日:2006-04-04

    IPC分类号: G01R31/28 G06F11/00

    CPC分类号: G06F11/2242

    摘要: A computer implemented method, data processing system, and computer usable code are provided for testing multi-core microprocessors. A test process initiates testing on communication bus interfaces associated with a set of processor cores on the multiprocessor in which the communication bus interfaces are disabled and wherein the testing uses a set of isolation test sequences to obtain results. The process identifies a set of functional processor cores in the set of processor cores based upon the results. The process also initiates a ramp logic built-in self-test to test a ramp associated with a functional processor core in the set of functional processor cores, wherein the ramp logic built-in self-test determines if the communication bus interface associated with functional processor core in the set of functional processor cores is functional.

    摘要翻译: 提供计算机实现的方法,数据处理系统和计算机可用代码用于测试多核微处理器。 测试过程启动与多处理器上的一组处理器核心相关联的通信总线接口上的测试,其中通信总线接口被禁用,并且其中测试使用一组隔离测试序列来获得结果。 该过程基于结果识别该组处理器核心中的一组功能处理器核心。 该过程还启动斜坡逻辑内置自检,以测试与功能处理器核心中的功能处理器核心相关联的斜坡,其中斜坡逻辑内置自检确定与功能性相关联的通信总线接口 处理器核心在功能处理器核心的功能。